Terms: = Colorectal cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
81 results:
1. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled timp1 as a regulator of ferroptosis in colorectal cancer.
Li M; Ni QY; Yu SY
Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in colorectal Adenocarcinoma and Their Response Targeting Immunotherapy.
Xu Y; Xie YM; Sun WS; Zi R; Lu HQ; Xiao L; Gong KM; Guo SK
Technol Cancer Res Treat; 2023; 22():15330338231212073. PubMed ID: 37920989
[No Abstract] [Full Text] [Related]
3. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract] [Full Text] [Related]
4. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma.
Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H
Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132
[TBL] [Abstract] [Full Text] [Related]
5. Role of stemness-related genes timp1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
Shen Y; Ni S; Li S; Lv B
Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
[TBL] [Abstract] [Full Text] [Related]
6. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
7. A prospective cohort study of timp1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract] [Full Text] [Related]
8.
Wijler LA; Dijk FJ; Quirindongo H; Raats DAE; Dorresteijn B; Furber MJW; May AM; Kranenburg O; van Dijk M
Oncotarget; 2022 Oct; 13():1094-1108. PubMed ID: 36242541
[TBL] [Abstract] [Full Text] [Related]
9. timp1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK/Akt signaling pathway.
Ma B; Ueda H; Okamoto K; Bando M; Fujimoto S; Okada Y; Kawaguchi T; Wada H; Miyamoto H; Shimada M; Sato Y; Takayama T
Cancer Sci; 2022 Dec; 113(12):4244-4257. PubMed ID: 36073574
[TBL] [Abstract] [Full Text] [Related]
10. colorectal cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and prognosis.
Qin Y; Li M; Lin Q; Pan X; Liang Y; Huang Z; Liu Z; Huang L; Fang M
Cancer Control; 2022; 29():10732748221121382. PubMed ID: 36036380
[TBL] [Abstract] [Full Text] [Related]
11. timp2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer.
Wang D; Xie B
Eur J Med Res; 2022 Jun; 27(1):91. PubMed ID: 35698180
[TBL] [Abstract] [Full Text] [Related]
13. Localized plasmonic sensor for direct identifying lung and colon cancer from the blood.
Lin C; Liang S; Li Y; Peng Y; Huang Z; Li Z; Yang Y; Luo X
Biosens Bioelectron; 2022 Sep; 211():114372. PubMed ID: 35598554
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract] [Full Text] [Related]
15. Predicting sulforaphane-induced adverse effects in colon cancer patients via in silico investigation.
Bozic D; Baralić K; Živančević K; Miljaković EA; Ćurčić M; Antonijević B; Djordjević AB; Bulat Z; Zhang Y; Yang L; Đukić-Ćosić D
Biomed Pharmacother; 2022 Feb; 146():112598. PubMed ID: 34959120
[TBL] [Abstract] [Full Text] [Related]
16. Fatty acid in colorectal cancer in adult and aged patients of both sexes.
T Juloski J; Popovic T; Martacic JD; V Cuk V; S Milic Perovic M; S Stankovic M; M Trbovich A; Luka SR
J BUON; 2021; 26(5):1898-1907. PubMed ID: 34761598
[TBL] [Abstract] [Full Text] [Related]
17. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: In silico analysis and validation.
Nazempour N; Taleqani MH; Taheri N; Haji Ali Asgary Najafabadi AH; Shokrollahi A; Zamani A; Fattahi Dolatabadi N; Peymani M; Mahdevar M
Exp Mol Pathol; 2021 Dec; 123():104688. PubMed ID: 34592197
[TBL] [Abstract] [Full Text] [Related]
18. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract] [Full Text] [Related]
19. Integrated Analysis of Gene Expression and Metabolite Data Reveals Candidate Molecular Markers in colorectal Carcinoma.
Yang J; Gao S; Qiu M; Kan S
Cancer Biother Radiopharm; 2022 Dec; 37(10):907-916. PubMed ID: 33259728
[No Abstract] [Full Text] [Related]
20. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in colorectal cancer.
Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
[TBL] [Abstract] [Full Text] [Related]
[Next]
